Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jet injection versus conventional pen for insulin reproducibility and pharmacologic profile
NL-OMON41800Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin aspart and human insulin in diabetes mellitus (DM) (3 arms), sponsored by Radboud University Medical Center. Primary endpoints: Variability in glucose lowering effect over four hours and Time to maximal glucose requirement. Started Jan 2015; status: active, not recruiting.
02
Drugs
insulin asparthuman insulin
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NL-OMON41800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41800.